OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 521 - 530 of 797 studies

Cancer and neoplasms

A Phase 1/2, Multicenter, First in Human, Dose Escalation and Expansion Study Evaluating CHM-029, as Monotherapy and in Combination with Standard Therapies in Participants with Relapsed or Refractory, or Newly Diagnosed Acute Myeloid Leukemia (AML) with NPM1 Mutations, KMT2A or NUP98 Rearrangements

Respiratory

An Open-label, Multi-center, Long-term Extension Study to Evaluate the Long-term Safety and Tolerability of Admilparant in Participants with Pulmonary Fibrosis. (IM0271016)

STRIDE-PsA: A Study of Treatment Response and Immunogenicity in Sequential Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drug (b/tsDMARD) Exposure in Psoriatic Arthritis (STRIDE-PsA)

Blood

Initial Safety and Efficacy, Sequential Group, Adaptive Dose Study of GL-2045 Subcutaneous Injection Repeat Doses in Patients with Immune Thrombocytopenia GL-2045-03 (GL-2045-03)

Blood Reproductive health and childbirth

HMBeacon: A Phase 2, Randomized, Double-blind Study of the Safety, Tolerability, Efficacy, and Pharmacodynamics of Multiple Dose ALN-6400 in Adult and Adolescent Female Patients with Von Willebrand Disease (VWD) and Heavy Menstrual Bleeding (HMB) (HMBeacon)

Cancer and neoplasms

ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer. (CA2660003 (ROSETTA CRC-203))

Oral and Gastrointestinal

A Phase 3, Randomized, Double-blind, and Active‑controlled Multicenter Study to Evaluate the Efficacy and Safety of JNJ‑78934804 in Participants With Moderately to Severely Active Crohn’s Disease (78934804CRD3001 (DUET ENCORE-CD))

Oral and Gastrointestinal

A Phase 3 Randomized, Double-blind, and Active-controlled, Multicenter Study to Evaluate the Efficacy and Safety of JNJ-78934804 in Participants with Moderately to Severely Active Ulcerative Colitis (DUET ENCORE-UC (7893480UCO3001))

Cancer and neoplasms

A Phase 1, Open-Label, Multicenter Study of INCA036978 in Participants With Myeloproliferative Neoplasms (INCA036978-101)

A pilot study: Sequential sampling of Blood and MRI based biomarkers of thrombogenesis following termination of Atrial Fibrillation episodes.